Tags: fda | schizophrenia | drug | abilify

New Schizophrenia Drug Gets Green Light

New Schizophrenia Drug Gets Green Light
(Copyright DPC)

Monday, 12 October 2015 01:05 PM

The U.S. Food and Druga Administration has approved an injectable drug to treat schizophrenia.
The drug is a long-acting version of aripiprazole (Abilify), and will be available in one-month and six-week formulations, Medical Page Today reports.

The FDA said the drug demonstrated efficacy in a 12-week trial of more than 600 patients. It will contain a boxed warning alerting healthcare professionals that there is an increased risk of death associated with off-label use, the drug agency said in an announcement posted on its website.

"Having a variety of treatment options and dosage forms available for patients with mental illness is important so that a treatment plan can be tailored to meet the patient's needs," said Mitchell Mathis, M.D., the director of psychiatry products at the FDA's Center for Drug Evaluation and Research, in a press release.

© 2019 NewsmaxHealth. All rights reserved.

   
1Like our page
2Share
Brain-Health
The FDA has approved an injectable drug to treat schizophrenia.
fda, schizophrenia, drug, abilify
136
2015-05-12
Monday, 12 October 2015 01:05 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved